ALLMedicine™ IgA Nephropathy Center
Research & Reviews 2,891 results
https://doi.org/10.1093/ndt/gfaa378
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association; Joher N, Gosset C et. al.
Jan 8th, 2021 - Little is known about clinical characteristics and kidney outcome in patients with biopsy-proven immunoglobulin A nephropathy (IgAN) in a context of inflammatory bowel disease (IBD). We conducted a retrospective multicenter study with centralized ...
https://doi.org/10.1016/j.kint.2020.12.028
Kidney International; Pawluczyk IZ, Didangelos A et. al.
Jan 8th, 2021 - Understanding why certain patients with IgA nephropathy progress to kidney failure while others maintain normal kidney function remains a major unanswered question. To help answer this, we performed miRnome profiling by next generation sequencing ...
https://doi.org/10.1007/s11255-020-02733-2 10.1056/NEJMra1206793 10.1681/ASN.2014101000 10.1016/j.ekir.2017.02.005 10.1038/nrdp.2016.1 10.1016/j.autrev.2009.11.007 10.1016/S0140-6736(12)60033-6 10.1097/MNH.0b013e3283436f5c 10.1016/j.molmed.2015.10.003 10.1038/nrneph.2012.58 10.1111/j.1600-065X.2008.00741.x 10.1016/j.clim.2007.10.005 10.4049/jimmunol.176.6.3635 10.4049/jimmunol.182.1.329 10.3389/fimmu.2017.01454 10.1016/j.jaci.2011.10.009 10.4049/jimmunol.1400395 10.18632/oncotarget.16836 10.1038/ncomms8360 10.1038/nrneph.2017.67 10.1002/jlb.63.5.636 10.1038/ki.2015.29 10.4049/jimmunol.1102603 10.4049/jimmunol.180.12.8048 10.1038/nchembio.481 10.4049/jimmunol.1301553 10.1016/j.intimp.2018.03.019 10.3389/fimmu.2019.01607 10.1172/jci.insight.139930
International Urology and Nephrology; Wei J, Wang Y et. al.
Jan 3rd, 2021 - Bruton's tyrosine kinase (BTK) is a vital biological molecule that contributes to immune regulation. Previous studies have showed that BTK can be detected in patients with lupus nephritis and rheumatoid arthritis. However, the role of BTK in IgA n...
https://www.ncbi.nlm.nih.gov/pubmed/33357358
Discovery Medicine; Li F, Wei RB et. al.
Dec 28th, 2020 - This study aims to investigate the influences of renal anemia on the pathogenesis of IgA nephropathy using propensity score matching (PSM). Renal biopsies from 462 patients with IgA nephropathy were enrolled in this study. PSM was used to balance ...
https://www.ncbi.nlm.nih.gov/pubmed/33357359
Discovery Medicine; Luo MN, Pan Q et. al.
Dec 28th, 2020 - Crescent formation is a serious pathological change in the IgA nephropathy (IgAN) which is believed to be primarily mediated by a mixture of parietal epithelial cells, macrophages, and myofibroblasts. It was recommended that IgAN patients with rap...
Guidelines 1 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956709
Clinical and Experimental Nephrology; Yuzawa Y, Yamamoto R et. al.
Apr 20th, 2016 - Evidence-based clinical practice guidelines for IgA nephropathy 2014.|2016|Yuzawa Y,Yamamoto R,Takahashi K,Katafuchi R,Tomita M,|diagnosis,etiology,therapy,
Clinicaltrials.gov 2,937 results
https://doi.org/10.1093/ndt/gfaa378
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association; Joher N, Gosset C et. al.
Jan 8th, 2021 - Little is known about clinical characteristics and kidney outcome in patients with biopsy-proven immunoglobulin A nephropathy (IgAN) in a context of inflammatory bowel disease (IBD). We conducted a retrospective multicenter study with centralized ...
https://doi.org/10.1016/j.kint.2020.12.028
Kidney International; Pawluczyk IZ, Didangelos A et. al.
Jan 8th, 2021 - Understanding why certain patients with IgA nephropathy progress to kidney failure while others maintain normal kidney function remains a major unanswered question. To help answer this, we performed miRnome profiling by next generation sequencing ...
https://doi.org/10.1007/s11255-020-02733-2 10.1056/NEJMra1206793 10.1681/ASN.2014101000 10.1016/j.ekir.2017.02.005 10.1038/nrdp.2016.1 10.1016/j.autrev.2009.11.007 10.1016/S0140-6736(12)60033-6 10.1097/MNH.0b013e3283436f5c 10.1016/j.molmed.2015.10.003 10.1038/nrneph.2012.58 10.1111/j.1600-065X.2008.00741.x 10.1016/j.clim.2007.10.005 10.4049/jimmunol.176.6.3635 10.4049/jimmunol.182.1.329 10.3389/fimmu.2017.01454 10.1016/j.jaci.2011.10.009 10.4049/jimmunol.1400395 10.18632/oncotarget.16836 10.1038/ncomms8360 10.1038/nrneph.2017.67 10.1002/jlb.63.5.636 10.1038/ki.2015.29 10.4049/jimmunol.1102603 10.4049/jimmunol.180.12.8048 10.1038/nchembio.481 10.4049/jimmunol.1301553 10.1016/j.intimp.2018.03.019 10.3389/fimmu.2019.01607 10.1172/jci.insight.139930
International Urology and Nephrology; Wei J, Wang Y et. al.
Jan 3rd, 2021 - Bruton's tyrosine kinase (BTK) is a vital biological molecule that contributes to immune regulation. Previous studies have showed that BTK can be detected in patients with lupus nephritis and rheumatoid arthritis. However, the role of BTK in IgA n...
https://www.ncbi.nlm.nih.gov/pubmed/33357358
Discovery Medicine; Li F, Wei RB et. al.
Dec 28th, 2020 - This study aims to investigate the influences of renal anemia on the pathogenesis of IgA nephropathy using propensity score matching (PSM). Renal biopsies from 462 patients with IgA nephropathy were enrolled in this study. PSM was used to balance ...
https://www.ncbi.nlm.nih.gov/pubmed/33357359
Discovery Medicine; Luo MN, Pan Q et. al.
Dec 28th, 2020 - Crescent formation is a serious pathological change in the IgA nephropathy (IgAN) which is believed to be primarily mediated by a mixture of parietal epithelial cells, macrophages, and myofibroblasts. It was recommended that IgAN patients with rap...
News 31 results
https://www.mdedge.com/fedprac/article/177898/hepatitis/hcv-hbv-and-hiv-associated-autoimmune-kidney-diseases
Mark S. Lesney
Oct 23rd, 2018 - Chronic viral infection can be associated with a variety of autoimmune kidney diseases, according to a review published in Rheumatic Disease Clinics. London_England/Thinkstock In particular, hepatitis C virus (HCV) infection can cause several kidn.
https://www.medscape.com/viewarticle/883905
Aug 6th, 2017 - A high rate of serious adverse events led to the premature termination of a clinical trial designed to evaluate the efficacy of oral methylprednisolone in patients with immunoglobulin A (IgA) nephropathy despite evidence of a statistically signifi...
https://www.medpagetoday.com/nephrology/generalnephrology/66990
Aug 1st, 2017 - Action Points Corticosteroid treatment in patients with IgA nephropathy was tied to an increased risk for serious adverse events. Note that most adverse events occurred during the first 3 months of treatment, and they were primarily driven by an e...
https://www.medscape.com/viewarticle/855965
Dec 14th, 2015 - The addition of an immunosuppressive regimen to ongoing comprehensive supportive care does not benefit patients with immunoglobulin A (IgA) nephropathy characterized by moderate proteinuria and chronic kidney disease stages 1 to 3, final results f...
https://reference.staging.medscape.com/viewarticle/849383_4
Aug 12th, 2015 - The patient meets the histopathologic criteria for solitary IgA nephropathy; the subsequent renal biopsy showed diffuse proliferative endocapillary glomerulonephritis with increased mesangial matrix and cellularity, capillary wall thickening, and ...
